Cancer Research 09 AM Call for Abstracts  SU2C
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maranchie, J. K.
Right arrow Articles by Zhan, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maranchie, J. K.
Right arrow Articles by Zhan, Y.
[Cancer Research 65, 9190-9193, October 15, 2005]
© 2005 American Association for Cancer Research


Priority Reports

Nox4 Is Critical for Hypoxia-Inducible Factor 2-{alpha} Transcriptional Activity in von Hippel-Lindau–Deficient Renal Cell Carcinoma

Jodi K. Maranchie and Ye Zhan

Departments of Surgery and Cell Biology, University of Massachusetts, Worcester, Massachusetts

Requests for reprints: Jodi K. Maranchie, Departments of Surgery and Cell Biology, University of Massachusetts, 55 Lake Avenue North, Worcester, MA 01655. Phone: 508-334-7887; Fax: 508-856-3137; E-mail: Jodi.maranchie{at}umassmed.edu.

Inactivation of the von Hippel-Lindau tumor suppressor (VHL) is an early event in >60% of sporadic clear cell renal cell carcinoma (RCC). Loss of VHL E3 ubiquitin ligase function results in accumulation of the {alpha}-subunit of the hypoxia-inducible heterodimeric transcription factor (HIF-{alpha}) and transcription of an array of genes including vascular endothelial growth factor, transforming growth factor-{alpha}, and erythropoietin. Studies have shown that HIF-{alpha} can be alternatively activated by reactive oxygen species. Nox4 is an NADP(H) oxidase that generates signaling levels of superoxide and is found in greatest abundance in the distal renal tubules. To determine if Nox4 contributes to HIF activity in RCC, we examined the impact of Nox4 expression on HIF-{alpha} expression and transactivation. We report here that small inhibitory RNA (siRNA) knockdown of Nox4 in 786-0 human renal tumor cells expressing empty vector (PRC) or wild-type VHL (WT) results in 50% decrease in intracellular reactive oxygen species as measured by a fluorescent 2',7'-dichlorofluorescin diacetate assay, and >85% reduction in HIF2-{alpha} mRNA and protein levels by quantitative reverse transcription-PCR and Western blot analysis. Furthermore, expression of the HIF target genes, vascular endothelial growth factor, transforming growth factor-{alpha}, and Glut-1 was abrogated by 93%, 74%, and 99%, respectively, after stable transfection with Nox4 siRNA relative to nontargeting siRNA, as determined by quantitative reverse transcription-PCR. Thus, renal Nox4 expression is essential for full HIF2-{alpha} expression and activity in 786-0 renal tumor cells, even in the absence of functional VHL. We propose the use of Nox4 as a target in the treatment of clear cell RCC.




This article has been cited by other articles:


Home page
Circ. Res.Home page
K. A. Sanders and J. R. Hoidal
The NOX on Pulmonary Hypertension
Circ. Res., August 3, 2007; 101(3): 224 - 226.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Orient, A. Donko, A. Szabo, T. L. Leto, and M. Geiszt
Novel sources of reactive oxygen species in the human body
Nephrol. Dial. Transplant., May 1, 2007; 22(5): 1281 - 1288.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Acker, J. Fandrey, and H. Acker
The good, the bad and the ugly in oxygen-sensing: ROS, cytochromes and prolyl-hydroxylases
Cardiovasc Res, July 15, 2006; 71(2): 195 - 207.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Geiszt
NADPH oxidases: New kids on the block
Cardiovasc Res, July 15, 2006; 71(2): 289 - 299.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.